サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1409370

創薬インフォマティクスの世界市場レポート 2024年

Drug Discovery Informatics Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
創薬インフォマティクスの世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

創薬インフォマティクスの市場規模は近年急速に拡大しています。2023年の33億6,000万米ドルから2024年には37億7,000万米ドルへと、CAGR12.2％で拡大します。歴史的な期間に観察された成長は、ゲノミクスとプロテオミクスの進歩、薬剤ターゲットの複雑化、構造生物学の進歩、アウトソーシングの増加、薬理ゲノミクスの統合、薬剤再利用戦略の実施に起因しています。

慢性疾患の増加は、創薬インフォマティクス市場の拡大を促進すると予想されます。慢性疾患は長期にわたって続くため、継続的な治療が必要となり、日常生活に支障をきたすことも少なくありません。創薬インフォマティクスシステムは、慢性疾患の治療を進める上で極めて重要な役割を果たします。これらのシステムにより、研究者は疾患の進行や薬物反応の根底にある複雑な分子変化を掘り下げることができ、その結果、健康な状態、疾患のある状態、治療を受けている状態にまたがる階層システムの包括的なモデルを得ることができます。例えば、2022年に世界保健機関（WHO）が発表した報告書では、非感染性疾患（NCDs）が4,100万人の死亡を引き起こし、世界の死亡者数の74％を占めると予測されています。これらの病気は、70歳までに毎年1,700万人の命を奪っており、低・中所得国が早死にの86％を占めています。年間死亡者数で最も多いのは心血管疾患（1,790万人）で、次いでがん（930万人）、慢性呼吸器疾患（410万人）、糖尿病（糖尿病による腎臓病を含む200万人）です。したがって、慢性疾患の有病率の増加が創薬インフォマティクス市場の成長を牽引しています。

2023年の創薬インフォマティクス市場で最大の地域は北米です。アジア太平洋は、予測期間中に創薬インフォマティクス市場で最も急成長する地域となる見込みです。創薬インフォマティクス市場レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 創薬インフォマティクス市場の特徴

第3章 創薬インフォマティクス市場の動向と戦略

第4章 創薬インフォマティクス市場- マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界の創薬インフォマティクス市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 創薬インフォマティクス市場セグメンテーション

  • 世界の創薬インフォマティクス市場、サービス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 社内
  • 外部委託
  • 世界の創薬インフォマティクス市場、モダリティ別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • クラウドベースのシステム
  • キャンパス内
  • 世界の創薬インフォマティクス市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • データの順序付け
  • 分子ドッキング
  • 識別と検証
  • 対象データ分析
  • 世界の創薬インフォマティクス市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製薬会社
  • 受託研究機関
  • バイオテクノロジー企業

第7章 創薬インフォマティクス市場の地域および国分析

  • 世界の創薬インフォマティクス市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の創薬インフォマティクス市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋の創薬インフォマティクス市場

第9章 中国の創薬インフォマティクス市場

第10章 インドの創薬インフォマティクス市場

第11章 日本の創薬インフォマティクス市場

第12章 オーストラリアの創薬インフォマティクス市場

第13章 インドネシアの創薬インフォマティクス市場

第14章 韓国の創薬インフォマティクス市場

第15章 西欧の創薬インフォマティクス市場

第16章 英国の創薬インフォマティクス市場

第17章 ドイツの創薬インフォマティクス市場

第18章 フランスの創薬インフォマティクス市場

第19章 イタリアの創薬インフォマティクス市場

第20章 スペインの創薬インフォマティクス市場

第21章 東欧の創薬インフォマティクス市場

第22章 ロシアの創薬インフォマティクス市場

第23章 北米創薬インフォマティクス市場

第24章 米国の創薬インフォマティクス市場

第25章 カナダの創薬インフォマティクス市場

第26章 南米創薬インフォマティクス市場

第27章 ブラジルの創薬インフォマティクス市場

第28章 中東の創薬インフォマティクス市場

第29章 アフリカの創薬インフォマティクス市場

第30章 創薬インフォマティクス市場の競合情勢と企業プロファイル

  • 創薬インフォマティクス市場の競合情勢
  • 創薬インフォマティクス市場の企業プロファイル
    • Accenture Plc.
    • Certara Inc.
    • Charles River Laboratories Inc.
    • Infosys Ltd.
    • Collaborative Drug Discovery Inc.

第31章 世界の創薬インフォマティクス市場の競合ベンチマーキング

第32章 世界の創薬インフォマティクス市場競争ダッシュボード

第33章 創薬インフォマティクス市場における主要な合併と買収

第34章 創薬インフォマティクス市場の将来展望と可能性分析

第35章 付録

目次
Product Code: r10908

“Drug Discovery Informatics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug discovery informatics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug discovery informatics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The drug discovery informatics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Service: In-House; Outsourced
  • 2) By Modality: Cloud-Based Systems; In-Campus
  • 3) By Application: Data Sequencing; Molecular Docking; Identification And Validation; Target Data Analysis
  • 4) By End-User: Pharmaceutical Companies; Contract Research Organizations; Bio-Technology Companies
  • Companies Mentioned: Accenture Plc.; Certara Inc.; Charles River Laboratories Inc.; Infosys Ltd.; Collaborative Drug Discovery Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Drug discovery informatics involves the development of systems designed to operate more efficiently with the vast volumes of clinical trial and treatment data. This field aims to facilitate the management of medical information, expediting the study and development of successful new treatments.

Key services in drug discovery informatics are categorized into in-house and outsourced solutions. In-house refers to computer programs, both in source and object code form, specifically tailored to the group's business needs and developed by the company itself rather than licensed from external sources. Various modalities, including cloud-based systems and in-campus applications, are employed for tasks such as data sequencing, molecular docking, identification and validation, as well as target data analysis. The end-users benefiting from these services encompass pharmaceutical companies, contract research organizations, and biotechnology companies.

The drug discovery informatics market research report is one of a series of new reports from The Business Research Company that provides drug discovery informatics market statistics, including drug discovery informatics industry global market size, regional shares, competitors with a drug discovery informatics market share, detailed drug discovery informatics market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery informatics industry. This drug discovery informatics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug discovery informatics market size has grown rapidly in recent years. It will grow from $3.36 billion in 2023 to $3.77 billion in 2024 at a compound annual growth rate (CAGR) of 12.2%. The growth observed during the historic period can be attributed to advancements in genomics and proteomics, the escalating complexity of drug targets, progress in structural biology, a rise in outsourcing practices, the integration of pharmacogenomics, and the implementation of drug repurposing strategies.

The drug discovery informatics market size is expected to see rapid growth in the next few years. It will grow to $6.06 billion in 2028 at a compound annual growth rate (CAGR) of 12.6%. The anticipated growth in the forecast period can be attributed to the expansion of precision medicine, advancements in drug-drug interaction prediction, analysis of patient-derived data, development of biosimilars, and the increasing number of drug candidates. Major trends expected in the forecast period encompass the integration of AI and machine learning, the use of digital twins in drug development, the adoption of collaboration platforms, the application of blockchain for data security, advancements in imaging technologies, and the utilization of cloud-based informatics platforms.

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the drug discovery informatics market. Chronic illnesses persist for extended periods, requiring ongoing medical attention and often hindering daily activities. Drug discovery informatics systems play a pivotal role in advancing chronic disease care. These systems enable researchers to delve into complex molecular changes underlying disease progression and drug response, resulting in comprehensive models of the hierarchical system across healthy, diseased, and treated states. For instance, a report by the World Health Organization in 2022 highlighted that non-communicable diseases (NCDs) are projected to cause 41 million deaths, accounting for 74% of global fatalities. These diseases claim 17 million lives annually before the age of 70, with low- and middle-income countries contributing to 86% of premature deaths. Cardiovascular diseases rank highest in annual fatalities (17.9 million), followed by cancer (9.3 million), chronic respiratory disorders (4.1 million), and diabetes (2.0 million, including diabetes-induced kidney disease). Hence, the growing prevalence of chronic diseases drives the growth of the drug discovery informatics market.

The increasing investment in research and development (R&D) activities is poised to fuel the expansion of the drug discovery informatics market. R&D activities encompass systematic and innovative endeavors undertaken by entities to enhance products, processes, or services. Investments in drug discovery informatics R&D contribute to a more efficient drug development process, improve data analysis, enhance target identification and validation, and enable predictive modeling of drug interactions and biological processes. For instance, according to the NCSES in January 2023, the US witnessed a total R&D investment of $791.9 billion in 2021, indicating a notable increase compared to the previous year. Thus, the surge in R&D investments drives the growth of the drug discovery informatics market.

Technological advancements stand out as a prominent trend driving the drug discovery informatics market. Leading companies in this sector prioritize the development of cutting-edge solutions to fortify their market positions. For instance, in January 2021, Certara Inc., a US-based biosimulation company, unveiled version 20 of its Simcyp Physiologically-based Pharmacokinetic (PBPK) Simulator platform. This updated version introduces improved maternal health models, specifically addressing medicine performance during pregnancy and lactation. The Simcyp PBPK Simulator enhances clinical trial efficiency by modeling and simulating pharmacokinetics (PK) and pharmacodynamics (PD) using virtual patient populations, particularly for biological drug development and predictive small molecule pharmacokinetics.

Leading companies within the drug discovery informatics market are directing their efforts toward innovative offerings, such as AI-powered solutions in life sciences, to drive market revenues. AI-driven solutions in life sciences are instrumental in advancing precision medicine and drug discovery, potentially revolutionizing the creation of new therapies and personalized treatment plans. These advancements aim to enhance the speed, accuracy, and efficiency of research and development processes within the life sciences industry. For instance, in May 2023, Google Cloud Platform, a US-based technology company, introduced AI-powered life sciences solutions such as the Target and Lead Identification Suite and the Multiomics Suite. These solutions aim to transform life sciences enterprises by expediting drug research and hastening the introduction of novel treatments. Utilizing high-performance computing, generative AI, and sophisticated computational tools, these methods predict protein structures, delineate the function of amino acids, and analyze genetic data. The Multiomics Suite contributes to precision medicine tools, while the Target and Lead Identification Suite aids in more effective in silico drug design.

In November 2022, Norstella, a US-based provider of pharmaceutical consultancy services and solutions, merged with Citeline. This strategic merger positions Norstella to prioritize rapid innovation, guiding life sciences companies throughout the entire drug development process, thereby accelerating the availability of medications for patients. Citeline, based in the US, specializes in providing pharmaceutical intelligence for research and development, offering insights into various drug trials. This merger signifies a significant step in facilitating swift and efficient drug development, ultimately benefiting patients by expediting the availability of essential medications.

Major companies operating in the drug discovery informatics market report are Accenture Plc., Certara Inc., Charles River Laboratories Inc., Infosys Ltd., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products Inc., Jubilant Biosys Ltd., Selvita S.A., PerkinElmer Inc., International Business Machines Corporation, Boehringer Ingelheim International GmbH, Oracle Corporation, Thermo Fisher Scientific Inc., Albany Molecular Research Inc., ChemAxon Ltd., Amazon Web Services Inc., Schrodinger LLC., Core Informatics LLC, Informatics Matters Ltd., Tata Consultancy Services Limited, Novo Informatics Pvt. Ltd., IO Informatics Inc., GVK Biosciences Private Limited, Dassault Systemes SE, Recursion Pharmaceuticals Inc., Cyclica Inc., Valence Discovery Inc., Valo Health Inc., Cognizant Technology Solutions Corporation, Wipro Limited, Mindtree Limited, Persistent Systems Limited, Laurson&Turbo Infotech Private Limited, Mphasis Limited .

North America was the largest region in the drug discover informatics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the drug discovery informatics market during the forecast period. The regions covered in the drug discovery informatics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug discovery informatics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug discovery informatics market consists of revenues earned by entities by providing literature databases, chemical databases, biological databases, predictive analytics, structures 2D and 3D, pharmacokinetic and pharmacodynamic data analysis, assay data analysis, genomics data analytics, and proteomics data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug discovery informatics market also includes sales of CI-based (continuous integration) design tools and pharmacophore modelling tools, which are used in providing drug discovery informatics services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Drug Discovery Informatics Market Characteristics

3. Drug Discovery Informatics Market Trends And Strategies

4. Drug Discovery Informatics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Drug Discovery Informatics Market Size and Growth

  • 5.1. Global Drug Discovery Informatics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drug Discovery Informatics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drug Discovery Informatics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug Discovery Informatics Market Segmentation

  • 6.1. Global Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • In-House
  • Outsourced
  • 6.2. Global Drug Discovery Informatics Market, Segmentation By Modality, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cloud-Based Systems
  • In-Campus
  • 6.3. Global Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Data Sequencing
  • Molecular Docking
  • Identification And Validation
  • Target Data Analysis
  • 6.4. Global Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Bio-Technology Companies

7. Drug Discovery Informatics Market Regional And Country Analysis

  • 7.1. Global Drug Discovery Informatics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drug Discovery Informatics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug Discovery Informatics Market

  • 8.1. Asia-Pacific Drug Discovery Informatics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug Discovery Informatics Market

  • 9.1. China Drug Discovery Informatics Market Overview
  • 9.2. China Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug Discovery Informatics Market

  • 10.1. India Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug Discovery Informatics Market

  • 11.1. Japan Drug Discovery Informatics Market Overview
  • 11.2. Japan Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug Discovery Informatics Market

  • 12.1. Australia Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug Discovery Informatics Market

  • 13.1. Indonesia Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug Discovery Informatics Market

  • 14.1. South Korea Drug Discovery Informatics Market Overview
  • 14.2. South Korea Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug Discovery Informatics Market

  • 15.1. Western Europe Drug Discovery Informatics Market Overview
  • 15.2. Western Europe Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug Discovery Informatics Market

  • 16.1. UK Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug Discovery Informatics Market

  • 17.1. Germany Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug Discovery Informatics Market

  • 18.1. France Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug Discovery Informatics Market

  • 19.1. Italy Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug Discovery Informatics Market

  • 20.1. Spain Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug Discovery Informatics Market

  • 21.1. Eastern Europe Drug Discovery Informatics Market Overview
  • 21.2. Eastern Europe Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug Discovery Informatics Market

  • 22.1. Russia Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug Discovery Informatics Market

  • 23.1. North America Drug Discovery Informatics Market Overview
  • 23.2. North America Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug Discovery Informatics Market

  • 24.1. USA Drug Discovery Informatics Market Overview
  • 24.2. USA Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug Discovery Informatics Market

  • 25.1. Canada Drug Discovery Informatics Market Overview
  • 25.2. Canada Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug Discovery Informatics Market

  • 26.1. South America Drug Discovery Informatics Market Overview
  • 26.2. South America Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug Discovery Informatics Market

  • 27.1. Brazil Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug Discovery Informatics Market

  • 28.1. Middle East Drug Discovery Informatics Market Overview
  • 28.2. Middle East Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug Discovery Informatics Market

  • 29.1. Africa Drug Discovery Informatics Market Overview
  • 29.2. Africa Drug Discovery Informatics Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drug Discovery Informatics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drug Discovery Informatics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug Discovery Informatics Market Competitive Landscape And Company Profiles

  • 30.1. Drug Discovery Informatics Market Competitive Landscape
  • 30.2. Drug Discovery Informatics Market Company Profiles
    • 30.2.1. Accenture Plc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Certara Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Charles River Laboratories Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Infosys Ltd.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Collaborative Drug Discovery Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Drug Discovery Informatics Market Competitive Benchmarking

32. Global Drug Discovery Informatics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Drug Discovery Informatics Market

34. Drug Discovery Informatics Market Future Outlook and Potential Analysis

  • 34.1 Drug Discovery Informatics Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Drug Discovery Informatics Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Drug Discovery Informatics Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer